PERIOPERATIVE COMPLICATIONS AND REMOTE RESULTS OF PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH STABLE ANGINA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE
https://doi.org/10.25207/1608-6228-2017-24-6-54-58
Abstract
Aim. To estimate the frequency of hospital complications and the long-term (duration of observation to 3 years) results of percutaneous coronary interventions (PCI) performed for stable effort angina in patients with chronic obstructive pulmonary disease (COPD). Materials and methods. Hospital complications were recorded after PCI in a series of 605 patients with stable effort angina with a history of long-term smoking, among which 142 patients with COPD were identified by spirography. For the prospective part of the study, 135 COPD patients and 216 patients in the control group were selected. During long-term follow-up (up to 3 years), the incidence of major cardiovascular events (MACCE) was recorded. Results. No effect of COPD on the incidence of hospital complications after PCI was found. The relative risk (RR) of major cardiovascular events in the long-term period was 1.36 (95% confidence interval 0.97-1.90). RR of revascularization was 1.77 (95% confidence interval 1.11-2.82). Conclusion. COPD does not affect the incidence of hospital complications after PCI, but increases the risk of MACCE in the long-term, mainly due to repeated myocardial revascularization.
About the Authors
V. K. ZAFIRAKI
Federal State Budgetary Educational Institution of Higher Education Kuban State Medical University of the Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
E. D. KOSMACHEVA
Scientific Research Institution – S.V. Ochapovsky Regional Clinical Hospital № 1
Russian Federation
Russian Federation
References
1. Windecker S., Kolh P., Windecker S., Alfonso F., Collet J.P., Cremer J., Falk V., Filippatos G., Hamm C., Head S.J., Jüni P., Kappetein A.P., Kastrati A., Knuuti J., Landmesser U., Laufer G., Neumann F.J., Richter D.J., Schauerte P., Sousa Uva M., Stefanini G.G., Taggart D.P., Torracca L., Valgimigli M., Wijns W., Witkowski A. 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg. 2014; 46(4): 517-92. doi: 10.1093/ejcts/ezu366.
2. Алекян Б.Г., Бузиашвили Ю.И., Голухова Е.З., Никитина Т.Г., Стаферов А.В., Закарян Н.В., Зимин В.Н., Фозилов Х.Г. Большие кардиальные осложнения при чрескожных коронарных вмешательствах – предикторы, причины развития, методы профилактики и алгоритмы лечебных мероприятий. Креативная кардиология. 2011; 1: 28-40. [Alekyan B.G., Buziashvili YU.I., Goluhova E.Z., Nikitina T.G., Staferov A.V., Zakaryan N.V., Zimin V.N., Fozilov H.G. Bol'shie kardial'nye oslozhneniya pri chreskozhnyh koronarnyh vmeshatel'stvah – prediktory, prichiny razvitiya, metody profilaktiki i algoritmy lechebnyh meropriyatij. Kreativnaya kardiologiya. 2011; 1: 28-40. (In Russ.)].
3. Enriquez J.R., Parikh S.V., Selzer F., Jacobs A.K., Marroquin O., Mulukutla S., Srinivas V., Holper E.M. Increased adverse events after percutaneous coronary intervention in patients with COPD: insights from the National Heart, Lung and Blood Institute dynamic registry. Chest. 2011; 140(3): 604-10. doi: 10.1378/chest.10-2644.
4. Dursunoglu N., Dursunoglu D., Yıldız A.İ., Uludag B., Alaçam Z.N., Sarıçopur A. A. Severity of coronary atherosclerosis in patients with COPD. Clin. Respir. J. 2017; 11(6): 751-756. doi: 10.1111/crj.12412.
5. Liang B.M., Xu Z.B., Yi Q., Ou X.M., Feng Y.L. Association of chronic obstructive pulmonary disease with coronary artery disease. Chin. Med. J. (Engl). 2013; 126(17): 3205-3208.
6. Topsakal R., Kalay N., Ozdogru I., Cetinkaya Y., Oymak S., Kaya M.G., Dogan A., Inanc M.T., Ergin A. Effects of chronic obstructive pulmonary disease on coronary atherosclerosis. Heart Vessels. 2009; 24(3): 164-8. doi: 10.1007/s00380-008-1103-4.
7. Nicholls S.J., Tuzcu E.M., Schoenhagen P., Sipahi I., Crowe T., Kapadia S., Nissen S.E. Effect of atorvastatin (80 mg/day) versus pravastatin (40 mg/day) on arterial remodeling at coronary branch points (from the REVERSAL study). Am. J. Cardiol. 2005; 96(12): 1636-9.
8. Zhang X.L., Chi Y.H., Wang le F., Wang H.S., Lin X.M. Systemic inflammation in patients with chronic obstructive pulmonary disease undergoing percutaneous coronary intervention. Respirology. 2014; 19(5): 723-9. doi: 10.1111/resp.12295
Review
For citations:
ZAFIRAKI V.K., KOSMACHEVA E.D. PERIOPERATIVE COMPLICATIONS AND REMOTE RESULTS OF PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH STABLE ANGINA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE. Kuban Scientific Medical Bulletin. 2017;(6):54-58. (In Russ.) https://doi.org/10.25207/1608-6228-2017-24-6-54-58
Views:
299
Email this article 